Clover Corporation Limited (CLV) - FY24 Results – Corner Turned in 2H24?
CLV is experiencing cyclically low demand for its products caused by a backlog of infant formula in China from a change in infant formula standards...
Clover Corporation Limited (CLV) - 1H24 Result – Infant Formula Continues to Be Tough
CLV is currently experiencing cyclically low demand for its products due to a backlog of infant formula in China and lower birth numbers in many...
Clover Corporation Limited (CLV) - Regulatory Catalysts To Drive Growth
CLV is the world leader in the manufacture of encapsulated Docosahexaenoic Acid (DHA) predominantly sold to infant formula manufacturers.
Aussie Healthcare Daily: 4 Dec 2017
The Aussie Healthcare Daily is a summary of major news and announcements from ASX-listed healthcare companies as well as developments and trends in...
Taxing Times For Australia
The Government's release of Re:think, its tax discussion paper, is a welcome development, designed to kick-start the conversation with the...
No more insights